Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.5%

- Check20 days agoChange DetectedThe page displays a government funding lapse notice and a site status message. The release note updates from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC metadata to revision 3.4.0 (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.2%

- Check42 days agoChange DetectedA revision note shows the page version updated from v3.3.3 to v3.3.4, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section appears with Ontario as a site for the study. The footer shows Revision: v3.3.3 and removes the old Ontario Locations link as well as the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check91 days agoChange DetectedA new PubMed publication entry (Murugavel et al., 2025) was added to the Publications section, and the revision tag was updated to v3.3.2.SummaryDifference0.2%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.